TYARENA Lactab 21 pce
7680623330017
CH-62333
G03AA15
1 / 3
google
Details
- Product number
- -
- CPT
- -
- Packaging group
- -
- Unit
- -
Official Swissmedic V2 data
Additional information from the official database
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
2.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
0.03 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
75.27 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | FNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | FTODK |
Authorization holder
Mepha Pharma AG
4051 Basel
Authorization information
- Swissmedic authorization number
- 62333
- Drug name
- Tyarena, Filmtabletten
- Galenic form
- FILM
- ATC Code
- G03AA15
- Authorization status
- Revoked/Withdrawn
- Dispensation category
- B
- First authorization
- 30/01/2012
- Authorization expiration date
- 01/05/2025
- IT number
- 09.02.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- TYARENA Lactab 21 pce
- Description (DE)
- TYARENA Lactab 21 Stk
- Market launch
- 30/01/2012
- Market withdrawal
- 01/05/2025
- Narcotic (BTM)
- No